Tapewire

Exchange unspecified · USD

IOBTQ

IO Biotech, Inc.

Export transactions ↓
Tapewire entity
8764
SEC CIK
0001865494
Parsed reports
97

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 09, 2021 Filed Nov 12, 2021 21:15 UTC
Nielsen JackDirector
ConversionCommon Stock 2,365,545 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-21-037652 · form4.xml · nonDerivative · entry 1

Nielsen Jack · CIK 0001602402 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,365,545

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Upon the closing of the Issuer's initial public offering, each share of Series C Preferred Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into the number of shares of Common Stock reported in Column 7 of Table II. These shares of Series C Preferred Stock had no expiration date.

F2 · ownership.nature: The securities are held by Vivo Capital Fund IX, L.P. ("Fund IX"). Vivo Capital IX, LLC ("Capital IX") is the general partner of Fund IX. The reporting person is a managing member of Capital IX and may be deemed to share voting and investment power with respect to the shares beneficially owned by Fund IX and disclaims Section 16 beneficial ownership of such securities held by Fund IX, except to the extent of his pecuniary interest therein, if any.

Read SEC document
November 04, 2021 Filed Nov 8, 2021 18:33 UTC
Zocca Mai-BrittDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 414,212 $0.00 Strike: $14.00 $0.00
Disclosure

SEC source: 0001140361-21-037038 · form4.xml · derivative · entry 1

Zocca Mai-Britt · CIK 0001890736 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 414,212

Underlying: Common Stock · 414,212 shares

Expires 2031-11-04

F1 · derivative.exercise_date: These options vest in 1/48 monthly increments of the vesting commencement date of November 4, 2021, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause or by the reporting person within 24 months of a change of control.

Read SEC document
November 04, 2021 Filed Nov 8, 2021 23:39 UTC GrantStock Option (Right to Buy) · Derivative 21,295 $0.00 Strike: $14.00 $0.00
Disclosure

SEC source: 0001140361-21-037044 · form4.xml · derivative · entry 1

Glaub Kathleen Sereda · CIK 0001619612 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,295

Underlying: Common Stock · 21,295 shares

Expires 2031-11-04

F1 · derivative.exercise_date: These options vest annually over three years from the vesting commencement date of November 4, 2021, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control.

Read SEC document
November 04, 2021 Filed Nov 8, 2021 23:37 UTC
Vendola Keith A.Chief Financial Officer
GrantStock Option (Right to Buy) · Derivative 69,469 $0.00 Strike: $14.00 $0.00
Disclosure

SEC source: 0001140361-21-037042 · form4.xml · derivative · entry 1

Vendola Keith A. · CIK 0001740994 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,469

Underlying: Common Stock · 69,469 shares

Expires 2031-11-04

F1 · derivative.exercise_date: These options vest 25% on the one-year anniversary of the vesting commencement date of November 4, 2021, and then in 1/48 monthly increments thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause or by the reporting person within 24 months of a change of control.

Read SEC document
November 04, 2021 Filed Nov 8, 2021 23:35 UTC
Hirth PeterDirector
GrantStock Option (Right to Buy) · Derivative 34,731 $0.00 Strike: $14.00 $0.00
Disclosure

SEC source: 0001140361-21-037040 · form4.xml · derivative · entry 1

Hirth Peter · CIK 0001813780 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,731

Underlying: Common Stock · 34,731 shares

Expires 2031-11-04

F1 · derivative.exercise_date: These options vest annually over three years from the vesting commencement date of November 4, 2021, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.